Nexobrid
Payments companies reported to CMS as associated with Nexobrid. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Nexobrid, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Nexobrid
These are the largest totals companies reported as associated with Nexobrid. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Steven Kahn | Charleston, SC | Surgery | $72,426.29 |
| Jeremy Goverman | Boston, MA | Surgical Critical Care | $56,016.35 |
| Brett Hartman | Indianapolis, IN | Plastic Surgery | $35,435.09 |
| Lucy Wibbenmeyer | Iowa City, IA | Surgical Critical Care | $27,889.14 |
| Steven Sandoval | Stony Brook, NY | Surgical Critical Care | $14,002.15 |
| Justin Routman | Birmingham, AL | Anesthesiology | $9,369.03 |
| William Hewgley | Birmingham, AL | Trauma Surgery | $8,957.49 |
| James Hwang | Birmingham, AL | Trauma Surgery | $8,455.95 |
| Alicia Lintner | Mobile, AL | Acute Care (Nurse Practitioner) | $8,248.86 |
| Brooke Burkey | Philadelphia, PA | Plastic Surgery | $7,489.33 |
Prescribed Nexobrid?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.